BASEL, Switzerland (Reuters) - Roche Holding AG missed full-year profit forecasts due to disappointing sales of key cancer drugs and gave a Lackluster ...
The head of Swiss pharmaceutical giant Novartis on Tuesday warned that governments now trying to cancel swine flu vaccine contracts might not be ...
By Dermot Doherty [Bloomberg] -- Novartis AG (NVS) offered to buy the rest of Alcon Inc. (ACL), the world's largest eye-care company, from Nestle SA (NSRGY) and minority shareholders for about $39.3 billion, as Chief Executive Officer Daniel Vasella expands into eye ...
By Carey Sargent [Bloomberg] -- Novartis AG may raise its $10.4 billion bid for the publicly traded stock of Alcon Inc., the world's largest eye-care company, to appease shareholders who are getting less than the Swiss drugmaker agreed to pay Nestle SA ...
Jan. 4 [Bloomberg] -- Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 11:20 a.m. in New York. Coal and metal producers advanced after reports showed manufacturing in the ...
Minority shareholders seek better price in Novartis' takeover of eye-care products maker Alcon The minority shareholders of eye-care products maker Alcon, Inc. have filed a class-action lawsuit to prevent Swiss pharmaceutical giant Novartis AG from completing a $39 billion takeover of the ...
Patenting arm at Univ. of Wis.-Madison wins lawsuit against Canadian drug company Xenon The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Canadian drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with ...
ZURICH (Reuters) - Alcon's independent directors have criticized a takeover bid from Novartis, saying the Swiss drugmaker is trying to circumvent protections for minority shareholders. Novartis aims to buy the rest of eye-care group Alcon for $39.3 billion to reduce its reliance ...
Swiss pharmaceuticals giant Novartis on Monday made a 40-billion-dollar play for the fast growing eye-care market, aiming to take over Alcon, the world's biggest company in a sector driven by an ageing population. Combined, Alcon and Novartis would have about 70 percent ...
Swiss pharmaceutical group Novartis said on Monday that it had bought a controlling stake in the world's biggest eye-care firm Alcon from Nestle and that it was seeking full ownership of Alcon. "Novartis intends to gain full ownership of Alcon Inc. by ...
Swiss drug maker Novartis plans to buy remaining stake in eye-care company Alcon for $38.5 bln Novartis AG said Monday it plans to take over Alcon Inc. by paying $38.5 billion for the 77 percent stake it does not already own in ...
Swiss pharmaceutical group Novartis on Monday said it had bought a controlling stake in the world's largest eye care firm Alcon from Nestle for 28.1 billion dollars (19.7 billion euros). The purchase of the additional 52 percent stake in Alcon follows a ...
